Bioptik Technology Incorporation (TPEX:4161)

TPEX:4161 Revenue

Bioptik Technology Incorporation had revenue of 237.60M TWD in the quarter ending June 30, 2026, with 24.73% growth. This brings the company's total for the last twelve months to 912.86M, up 10.76% year-over-year. In the year 2025, Bioptik Technology Incorporation had annual revenue of 837.19M, down -3.25%. That makes Bioptik Technology Incorporation the 31,799th largest company in the world by revenue and 1,624th in Taiwan.

• Revenue (ttm): 912.86M
• Revenue Growth: +10.76%
• P/S Ratio: 1.39
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 1.27B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Medical Testing Equipment 674.80M 80.6%
• Maintenance (Health) Products Department 162.39M 19.4%

By Geography

Chart

• Taiwan 737.52M 88.1%
• Other 99.67M 11.9%

Fiscal year ended Dec 31, 2025 See the full TPEX:4161 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	837.19M	-28.14M	-3.25%
Dec 31, 2024	865.34M	36.83M	4.45%
Dec 31, 2023	828.50M	60.75M	7.91%
Dec 31, 2022	767.75M	29.86M	4.05%
Dec 31, 2021	737.89M	252.29M	51.96%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error